However, combination therapy was associated with an increased risk of diarrhea (any grade and grade ≥3), hypothyroidism (any grade or grade ≥3), decreased appetite (grade ≥3), increased aspartate aminotransferase levels (grade ≥3), and increased alanine transaminase levels (any grade). The gene discussed is GPT; the disease is hypothyroidism.